AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Global Heart Defect Closure Devices Market Outlook, 2023: Anticipated to Grow at Over 29% - Rising Focus on R&D of Bio-Absorbable Occluders - ResearchAndMarkets.com

February 21, 2019

DUBLIN--(BUSINESS WIRE)--Feb 21, 2019--The “Global Heart Defect Closure Devices Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The heart defect closure devices market will register CAGR of over 29% by 2023.

AF is the most commonly encountered arrhythmia in clinical practice. It is associated with increased morbidity, especially stroke and heart failure, and mortality.

AF is becoming a major public health burden across the world, and its prevalence is expected to increase due to the rapidly growing geriatric population, especially in developing countries. Other risk factors of AF such as high blood pressure (BP), obesity, diabetes, heart failure, ischemic heart disease, chronic kidney disease (CKD), and the heavy consumption of alcohol are also on the rise.

Hence, the rising prevalence of AF will increase the demand for LAA closure therapy, which will drive the growth of the global heart defect closure devices market.

Technological advances in heart defect closure

There had been several significant technological advances in all forms of cardiovascular care. especially in the treatment of structural heart disease, in the last decade. The advances in catheterization techniques, medical imaging, and devices have increased the adoption of minimally invasive procedures. Therefore, interventional cardiology procedures have now become the standard of care to treat ASD and PFO.

Shortage of skilled surgeons to perform heart defect closure procedures

There is a global shortage of cardiologists, including general cardiologists, electrophysiologists: interventional cardiologists, both coronary and peripheral, and pediatric cardiologists. This shortage is attributed to the aging cardiology community, limited growth in fellowship positions, increasing burden of cardiovascular diseases (CVDs): and evolving health care reforms.

Competitive Landscape

The market appears to be moderately concentrated with the presence of few vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

Key Players

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

PART 12: VENDOR ANALYSIS

For more information about this report visit https://www.researchandmarkets.com/research/n5wdk2/global_heart?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190221005423/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Devices

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/21/2019 06:01 AM/DISC: 02/21/2019 06:01 AM

http://www.businesswire.com/news/home/20190221005423/en